Toshiaki Takahashi1, Naoki Suzuki2, Rumiko Izumi2,3, Chikako Yaginuma4, Hiroya Ono2,5, Naoko Shimakura2, Saki Oshiro1, Yoko Sugimura1, Sayaka Taniguchi1, Yasuko Shimosegawa6, Toru Baba1, Hideki Oizumi1, Hiroyasu Tanaka1, Masaru Yoshioka1,4, Hitoshi Warita2, Tetsuya Niihori7, Atsushi Takeda1, Yoko Aoki7, Masashi Aoki2 (1.Department of Neurology, NHO Sendai-Nishitaga National Hospital, 2.Department of Neurology, Tohoku University School of Medicine, 3.Department of Neurology, Minami Tohoku Hospital, 4.Department of Clinical Laboratory, NHO Sendai-Nishitaga National Hospital, 5.Department of Neurology, NHO Iwate National Hospital, 6.Department of Neurosurgery, NHO Sendai-Nishitaga National Hospital, 7.Department of Medical Genetics, Tohoku University School of Medicine)
Session information
Oral Session
[O-45] Neurogenetics/ Gene therapy (Clinical research)
Sat. May 25, 2019 10:15 AM - 11:45 AM Room 10 (Osaka International Convention Center 12F Grande Toque)
Chair:Yoshihisa Takiyama(Department of Neurology, University of Yamanashi)
Yuta Ichinose1, Haitian Nan1, Kishin Koh1, Masaki Tanaka2, Hiroyuki Ishiura3, Jun Mitsui3, Kana Shimomura4, Masafumi Morimoto5, Shun Hamada6, Toshihisa Ohtsuka6, Shoji Tsuji2,3, Yoshihisa Takiyama1 (1.Department of Neurology, University of Yamanashi, 2.Department of Neurology, International University of Health and Welfare, 3.Department of Neurology, The University of Tokyo, 4.Department of Neurology, Yokohama General Hospital, 5.Department of Pediatrics, Kyoto Prefectural University of Medicine, 6.Department of Biochemistry, Faculty of Medicine, University of Yamanashi)
Kishin Koh1, Hiroyuki Ishiura2, Haruo Shimazaki3, Michiko Tsutsumiuchi4,5, Akane Satake1, Mai Tsuchiya1, Haitian Nan1, Yuta Ichinose1, Takamura Nagasaka1, Shoji Tsuji6, Yoshihisa Takiyama1 (1.Department of Neurology, University of Yamanashi, 2.Department of Neurology, The University of Tokyo, 3.Division of Neurology, Department of Medicine, Jichi Medical University, 4.Department of Neurology, Toranomon Hospital, 5.Department of Neurology, Jichi Medical University Saitama Medical Center, 6.Department of Molecular neurology, The University of Tokyo)
Saki Hayashi1, Takekazu Ohi1, Kei Sato1, Yoshihiro Takeuchi2, Masafumi Morimoto3, Hiroki Takeuchi4, Ken Miyanomaei5 (1.Uji Hospital,Department of Neurology, 2.Division of Developmental and Behavioral Pediatrics Shiga University of Medical Science, 3.Kyoto Prefectural University of Medicine,Department of Pediatrics, 4.Minami Kyoto Hospital,Department of Neurology, 5.Minami Kyoto Hospital,Department of Pediatrics)
Haruo Shimazaki1, Ryo Sugaya1, Natsumi Watanabe2, Takafumi Mashiko1, Junji Yamauchi2, Shigeru Fujimoto1 (1.Division of Neurology, Department of Internal Medicine, Jichi Medical University, 2.Laboratory of Molecular Neuroscience and Neurology, School of Life Science, Tokyo University of Pharmacy and Life Sciences)
Kokoro Ozaki1, Ayaka Ansai1, Kouji Nobuhara2, Toshihiko Araki3, Takayuki Kubodera4, Takashi Ishii1, Miwa Higashi1, Nozomu Sato1, Kazumasa Soga1, Hidehiro Mizusawa5, Kinya Ishikawa6, Takanori Yokota1 (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 2.Department of Neurology, Kubo-naika Hospital, 3.Department of Neurology, Kawaguchi Municipal Medical Center, 4.Department of Neurology, Nissan Tamagawa Hospital, 5.National Center of Neurology and Psychiatry, 6.The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University)